PMC:7696151 / 35595-35890
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1048 | 53-56 | Chemical | denotes | HCQ | MESH:D006886 |
| 1049 | 240-243 | Chemical | denotes | HCQ | MESH:D006886 |
| 1061 | 73-81 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1062 | 82-91 | Disease | denotes | infection | MESH:D007239 |
| 1063 | 167-175 | Disease | denotes | Covid-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T235 | 0-295 | Sentence | denotes | After 14 days of treatment, it was demonstrated that HCQ did not prevent COVID-19 infection when compared to placebo, since the incidence of illnesses compatible with Covid-19 disease did not differ significantly between subjects receiving HCQ (49 of 414 (11.8%)) or placebo (58 of 407 (14.3%)). |